Oxford Biomedica PLC 2019 Annual Report with Sustainability Disclosures
Company: Oxford Biomedica PLC
Sector: Professional & technical services
Country: United Kingdom
Year: 2019
Type: Annual Report with Sustainability Disclosures
Pages: 158
The report records 2019 revenue of £64.1 million and year-end headcount of 554, while bioprocessing and commercial development revenue rose 17%. It highlights a five-year extension of the Novartis supply agreement and a new Santen partnership. Facility expansion progressed with the Oxbox production suites' building phase completed and the Windrush Innovation Centre occupied during the year.
Indicators available in this report: